Details for Patent: 8,252,328
✉ Email this page to a colleague
Which drugs does patent 8,252,328 protect, and when does it expire?
Patent 8,252,328 protects DSUVIA and is included in one NDA.
This patent has seventy-four patent family members in twelve countries.
Summary for Patent: 8,252,328
| Title: | Bioadhesive drug formulations for oral transmucosal delivery |
| Abstract: | Formulations for controlled delivery of oral transmucosal medications are provided. The formulations are characterized as hydrogel-forming or eroding-types which are bioadhesive and provide for controlled and sustained release of the medication such that enhanced bioavailability and efficacy is provided. |
| Inventor(s): | Tzannis; Stelios (Newark, CA), Palmer; Pamela (San Francisco, CA), Schreck; Thomas (Portola Valley, CA), Hamel; Larry (Mountain View, CA), Poutiatine; Andrew I. (San Anselmo, CA) |
| Assignee: | Acelrx Pharmaceuticals, Inc. (Redwood City, CA) |
| Application Number: | 11/650,227 |
|
Patent Claim Types: see list of patent claims | Composition; Formulation; Delivery; Dosage form; |
Drugs Protected by US Patent 8,252,328
| Applicant | Tradename | Generic Name | Dosage | NDA | Approval Date | TE | Type | RLD | RS | Patent No. | Patent Expiration | Product | Substance | Delist Req. | Patented / Exclusive Use | Submissiondate |
|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|
| Vertical Pharms | DSUVIA | sufentanil citrate | TABLET;SUBLINGUAL | 209128-001 | Nov 2, 2018 | RX | Yes | Yes | ⤷ Sign Up | ⤷ Sign Up | Y | ⤷ Sign Up | ||||
| >Applicant | >Tradename | >Generic Name | >Dosage | >NDA | >Approval Date | >TE | >Type | >RLD | >RS | >Patent No. | >Patent Expiration | >Product | >Substance | >Delist Req. | >Patented / Exclusive Use | >Submissiondate |
International Family Members for US Patent 8,252,328
| Country | Patent Number | Estimated Expiration | Supplementary Protection Certificate | SPC Country | SPC Expiration |
|---|---|---|---|---|---|
| European Patent Office | 2114383 | ⤷ Sign Up | 300797 | Netherlands | ⤷ Sign Up |
| European Patent Office | 2114383 | ⤷ Sign Up | CA 2016 00007 | Denmark | ⤷ Sign Up |
| European Patent Office | 2114383 | ⤷ Sign Up | CR 2016 00007 | Denmark | ⤷ Sign Up |
| European Patent Office | 2114383 | ⤷ Sign Up | 122016000023 | Germany | ⤷ Sign Up |
| European Patent Office | 2114383 | ⤷ Sign Up | 16C0010 | France | ⤷ Sign Up |
| >Country | >Patent Number | >Estimated Expiration | >Supplementary Protection Certificate | >SPC Country | >SPC Expiration |
